CAMP4 Therapeutics Corporation (CAMP) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -10.98M | 6.29M | -11.22M | -10.34M | -14.29M | -11.29M | -9.69M | -13.44M | -11.14M | -11.78M | -6.55M | -2.98M |
| Operating CF Margin % | -848.61% | 1808.33% | -1410.94% | -690.92% | -1665.03% | -1731.29% | - | - | - | - | -1872.57% | -4.2% |
| Operating CF Growth % | 23.13% | 155.75% | -15.72% | 23.03% | -28.21% | 4.2% | -47.89% | -350.94% | -921.36% | -407.33% | 35.27% | 80.84% |
| Net Income | -18.33M | -40.28M | -15.1M | -12.59M | -12.43M | -13.28M | -13.48M | -12.58M | -12.45M | -12.99M | -11.7M | -12.3M |
| Depreciation & Amortization | 520K | 372K | 416K | 430K | 421K | 418K | 418K | 424K | 436K | 435K | 430K | 406.5K |
| Stock-Based Compensation | 0 | 1.15M | 984K | 1M | 861K | 797K | 1.59M | 786K | 856K | 636K | 722K | 774.5K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -304K |
| Other Non-Cash Items | 7.7M | 28.38M | 2.85M | 194K | 376K | 8K | 1.55M | -590K | 1.42M | 298K | 855K | 10.01M |
| Working Capital Changes | -865K | 16.67M | -369K | 618K | -3.51M | 768K | 229K | -1.48M | -1.4M | -162K | 3.13M | -1.56M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 592K | -467K | -546K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 36K | -279K | -279K | -263K | -178K | -163K | -15K | -243K | -207K | -1.96M |
| Capital Expenditures | 0 | 0 | 36K | -279K | -279K | -263K | -178K | -163K | -15K | -243K | -207K | -114K |
| CapEx % of Revenue | - | - | 4.53% | 18.64% | 32.52% | 40.34% | - | - | - | - | 59.14% | 0.16% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.84M |
| Cash from Financing | 57K | 28.59M | 47.38M | 72K | -151K | 73.06M | -386K | -812K | -202K | -63K | -203K | -257K |
| Debt Issued (Net) | 0 | -18K | -14K | 72K | -151K | -211K | -205K | -204K | -204K | -236K | -204K | - |
| Equity Issued (Net) | 57K | 28.6M | 32.56M | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 14.84M | 0 | 0 | 73.27M | -181K | -608K | 2K | 173K | 0 | -257K |
| Net Change in Cash | -10.92M | 34.88M | 36.2M | -10.55M | -14.72M | 61.51M | -10.26M | -14.41M | -11.36M | -12.09M | -6.96M | -6.97M |
| Free Cash Flow | -10.98M | 6.29M | -11.22M | -10.34M | -14.56M | -11.55M | -9.69M | -13.6M | -11.16M | -12.03M | -6.76M | -3.09M |
| FCF Margin % | -848.61% | 1808.33% | -1410.94% | -690.92% | -1697.55% | -1771.63% | - | - | - | - | -1931.71% | -4.36% |
| FCF Growth % | 24.61% | 154.48% | -15.72% | 23.95% | -30.53% | 3.95% | -43.37% | -339.59% | -825.98% | -2013.54% | 40.62% | 83.87% |
| FCF per Share | -0.19 | 0.12 | -0.56 | -0.51 | -0.75 | -0.59 | -0.50 | -0.86 | -0.92 | -0.32 | -0.18 | -0.08 |
| FCF Conversion (FCF/Net Income) | 0.60x | -0.16x | 0.74x | 0.82x | 1.15x | 0.85x | 0.72x | 1.07x | 0.89x | 0.91x | 0.56x | 0.74x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |